NEXT GENERATION SOLUTIONS
AltruBio is developing first-in-class drugs and novel best-in-class therapeutics for inflammatory/autoimmune diseases and cancers.
AltruBio is developing first-in-class drugs and novel best-in-class therapeutics for inflammatory/autoimmune diseases and cancers.
b1/20181003095312vbaztkTvY1.jpg)
Financial Information
AltruBio is a privately held company based in Bay Area, California and Taipei, Taiwan. For more info Please contact us at finance@altrubio.com
b1/201810030953121z377tHuo2.jpg)
Stock Information
b1/20181003095313ns8qko1oS3.jpg)
Events & Presentation
b1/20181003095313kb2e051XN4.jpg)
Governance
AltruBio has established two functional committees under the board of directors: Audit Committee and Compensation Committee. AltruBio is committed to sound principles of corporate governance and believes that such principles are critical to our success as a company and to obtaining the trust and confidence of our shareholders and employees.
In order to ensure that the "stakeholder" (employees, shareholders, banks, consumers, and suppliers) have direct and communication channels with the Audit Committee to respect and maintain their rights.
The Audit committeeaudit@altrubio.com
b1/20181003095313nbwpplqY35.jpg)
Corporate Social Responsibility
At AltruBio we’re united by our desire to push the boundaries of science. We have a passion for helping patients. It is this passion which fuels the work we do every day to bring innovative and empowered new therapies to those in need.
IR Contact
Contact Us